Therapeutic Asset Ratings

9,928 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Doxycycline Female Reproductive Organ Cancer	M.D. Anderson Cancer Center	P1	CC (43)
Doxycycline Male Reproductive Organ Cancer	M.D. Anderson Cancer Center	P1	CC (43)
Doxycycline Malignant Mesothelioma	M.D. Anderson Cancer Center	P1	CC (43)
Doxycycline Malignant Endocrine Neoplasm	M.D. Anderson Cancer Center	P1	CC (43)
Dp Cd8 Til Malignant Urinary System Neoplasm	AgonOx, Inc.	P1	CC (43)
dr-0202 Castration-Resistant Prostate Carcinoma	Dren Bio	P1	CC (43)
dr-0202 Gastroesophageal Junction Adenocarcinoma	Dren Bio	P1	CC (43)
Dri Cell Therapy Brain Cancer	University of Alabama at Birmingham	P1	CC (43)
ds-9606a Germ Cell Tumor	Daiichi Sankyo	P1	CC (43)
Dual-Target Car-Nk Cells Malignant Glioma	Beijing Biotech	P1	CC (43)
Dual-Targeting Bcma-Gprc5D Car-T Cell Infusion Plasma Cell Myeloma	Beijing GoBroad Hospital	P1	CC (43)
Duoc-01 Adrenoleukodystrophy	Joanne Kurtzberg, MD	P1	CC (43)
Duoc-01 Alpha-Mannosidosis	Joanne Kurtzberg, MD	P1	CC (43)
Duoc-01 Juvenile Neuronal Ceroid Lipofuscinosis	Joanne Kurtzberg, MD	P1	CC (43)
Duoc-01 Inborn Errors Of Metabolism	Joanne Kurtzberg, MD	P1	CC (43)
Duoc-01 Krabbe Disease	Joanne Kurtzberg, MD	P1	CC (43)
Duoc-01 Metachromatic Leukodystrophy	Joanne Kurtzberg, MD	P1	CC (43)
Duoc-01 Mucopolysaccharidosis Type 2	Joanne Kurtzberg, MD	P1	CC (43)
Duoc-01 Niemann-Pick Disease	Joanne Kurtzberg, MD	P1	CC (43)
Duoc-01 Pelizaeus-Merzbacher Spectrum Disorder	Joanne Kurtzberg, MD	P1	CC (43)
Duoc-01 Sandhoff Disease	Joanne Kurtzberg, MD	P1	CC (43)
Duoc-01 Mucopolysaccharidosis Type 3	Joanne Kurtzberg, MD	P1	CC (43)
Duoc-01 Tay-Sachs Disease	Joanne Kurtzberg, MD	P1	CC (43)
Durvalumab High Grade Malignant Neoplasm	AstraZeneca	P1	CC (43)
Durvalumab Cervical Squamous Cell Carcinoma	NeoTX Therapeutics Ltd.	P1	CC (43)

Showing 1851 to 1875 of 9,928 assets

PreviousPage 75 of 398Next